-
Cohen co-authors "Pre-exposure Prophylaxis for HIV - Where Do We Go from Here?" in the New England Journal of Medicine
-
Myron Cohen, MD, collaborated with Lindsay Bahen, MD, from Brigham and Women's Hospital in Boston, Mass., for this editorial that was published in the New England Journal of Medicine.
Located in
Vital Signs
/
2012
/
July 19
-
UNC researcher: Racial disparities in HIV infection rate are ‘indictment’ of U.S. response to epidemic
-
UNC's Dr. Adaora A. Adimora and her fellow researchers examine factors responsible for the stark racial disparities in HIV infection in the U.S. and the now concentrated epidemic among African Americans.
Located in
Vital Signs
/
Archives
/
Vital Signs - Oct. 9, 2009
-
UNC Awarded $3.5 Million to Study HIV Transmission Prevention Among Newly Infected
-
A team of researchers from the UNC Institute for Global Health & Infectious Diseases has received a $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study HIV prevention methods among people with acute HIV infection (AHI).
Located in
Vital Signs
/
2009
/
Vital Signs - July 31, 2009
-
UNC Has Strong Presence at 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
-
Faculty and students from UNC presented over 40 abstracts at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, which took place July 19-22, 2009 in Cape Town, South Africa.
Located in
Vital Signs
/
2009
/
Vital Signs - July 24, 2009
-
Adimora wins 2011 Mary Turner Lane award
-
Adaora Adimora, professor in the School of Medicine and clinical professor of epidemiology in the Gillings School of Global Public Health, has won the 2011 Mary Turner Lane Award.
Located in
Vital Signs
/
2011
/
May 19
-
PrEP treatment prevented HIV transmission in humanized mice
-
Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE.
Located in
Vital Signs
/
2010
/
Vital Signs - Jan. 21, 2010
-
UNC study will test therapies to eradicate HIV infection—medicine’s holy grail
-
Researchers from the UNC Institute for Global Health & Infectious Diseases have received $2.7 million from the National Institutes of Health to develop and test new therapeutic agents that may eradicate HIV infection.
Located in
Vital Signs
/
2009
/
Vital Signs - Sept. 11, 2009
-
NIAID grant launches Kashuba's plan for HIV-prevention trials
-
Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world.
Located in
Vital Signs
/
Archives
/
Vital Signs - Jan. 4, 2010
-
Cohen appointed to PEPFAR Scientific Advisory Board
-
Myron Cohen, MD, director of the UNC Institute for Global Health & Infectious Diseases and chief of the Division of Infectious Diseases in the Department of Medicine, has been appointed to the new Scientific Advisory Board of the President’s Emergency Plan for AIDS Relief (PEPFAR).
Located in
Vital Signs
/
2011
/
Jan. 13
-
UNC Awarded $3.5 Million to Study HIV Transmission Prevention Among Newly Infected
-
A team of researchers from the UNC Institute for Global Health & Infectious Diseases has received a $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to study HIV prevention methods among people with acute HIV infection (AHI).
Located in
Vital Signs
/
Archives
/
Vital Signs - July 31, 2009